ARCHIVES

NCI Calls Fisher “A Dominant Force” In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 23 No. 34 | September 5, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

NIH Probing: Double Dipping” Allegation

September 4, 1981

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002